For our tumor models, we used six different syngeneic mouse tumor cell lines. The CT26 cancer cell line was obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into BALB/c mice subcutaneously at 1×106 cells per mouse. The MC-38 cancer cell line was obtained from NCI/NIH, maintained in RPMI-10% FBS at 37°C, and implanted into C57B6/J mice subcutaneously at 2×105 cells per mouse. The EMT6 cancer cell line was obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into BALB/c mice subcutaneously at 2×105 cells per mouse. The LL2 cancer cell line was obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into C57B6/J mice subcutaneously at 2×105 cells per mouse. The Sa1N cancer cell line was obtained from ATCC, maintained in Eagle’s Minimum Essential Medium (EMEM, ATCC 30–2003) at 37°C, and implanted into A/J mice subcutaneously at 1 ×106 cells per mouse. The B16-F10 cancer cell line as obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into C57B6/J mice subcutaneously at 2×105 cells per mouse.
B16 f10 cancer cell line
Manufactured by American Type Culture Collection
The B16-F10 cell line is a murine melanoma cell line derived from C57BL/6 mice. It is a highly metastatic cell line commonly used in cancer research.
Automatically generated - may contain errors
2 protocols using b16 f10 cancer cell line
1
Syngeneic Mouse Tumor Cell Line Implantation
2
Syngeneic Mouse Tumor Cell Line Implantation
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
For our tumor models, we used six different syngeneic mouse tumor cell lines. The CT26 cancer cell line was obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into BALB/c mice subcutaneously at 1×106 cells per mouse. The MC-38 cancer cell line was obtained from NCI/NIH, maintained in RPMI-10% FBS at 37°C, and implanted into C57B6/J mice subcutaneously at 2×105 cells per mouse. The EMT6 cancer cell line was obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into BALB/c mice subcutaneously at 2×105 cells per mouse. The LL2 cancer cell line was obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into C57B6/J mice subcutaneously at 2×105 cells per mouse. The Sa1N cancer cell line was obtained from ATCC, maintained in Eagle’s Minimum Essential Medium (EMEM, ATCC 30–2003) at 37°C, and implanted into A/J mice subcutaneously at 1 ×106 cells per mouse. The B16-F10 cancer cell line as obtained from ATCC, maintained in RPMI-10% FBS at 37°C, and implanted into C57B6/J mice subcutaneously at 2×105 cells per mouse.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!